Company intelligence / Profile preview

AS Kevelt

Tallinn, Estoniakevelt.ee ↗
Ownership
Private
Employees
~49
Development stage
Commercial
01

Overview

Manufactures and markets prostaglandin-based pharmaceuticals for obstetrics, vasculature disease, and glaucoma treatment. Also produces skin care products for vitiligo patients.

Therapeutic areas
Women's HealthOphthalmologyCardiovascularDermatology
Modalities
Prostaglandin-based pharmaceuticalsbiological pharmaceuticals
Industry
Biotech
02

Drug pipeline

2 assets

Vasostenoon

4

1 more asset in the full pipeline.

03

Partnerships

Latvian companies Vitesan and LatimaCompetence Centre for Cancer Research (CCCR)Life Science Investments (LSI)Lysaskin LaboratoiresOrigen company

Beyond the preview

Go deeper on AS Kevelt.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AS Kevelt.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call